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ABSTRACT: Carbanionic intermediates play a central role in
the catalytic transformations of amino acids performed by
pyridoxal-5′-phosphate (PLP)-dependent enzymes. Here, we
make use of NMR crystallographythe synergistic combina-
tion of solid-state nuclear magnetic resonance, X-ray
crystallography, and computational chemistryto interrogate
a carbanionic/quinonoid intermediate analogue in the β-
subunit active site of the PLP-requiring enzyme tryptophan
synthase. The solid-state NMR chemical shifts of the PLP
pyridine ring nitrogen and additional sites, coupled with first-principles computational models, allow a detailed model of
protonation states for ionizable groups on the cofactor, substrates, and nearby catalytic residues to be established. Most
significantly, we find that a deprotonated pyridine nitrogen on PLP precludes formation of a true quinonoid species and that
there is an equilibrium between the phenolic and protonated Schiff base tautomeric forms of this intermediate. Natural bond
orbital analysis indicates that the latter builds up negative charge at the substrate Cα and positive charge at C4′ of the cofactor,
consistent with its role as the catalytic tautomer. These findings support the hypothesis that the specificity for β-elimination/
replacement versus transamination is dictated in part by the protonation states of ionizable groups on PLP and the reacting
substrates and underscore the essential role that NMR crystallography can play in characterizing both chemical structure and
dynamics within functioning enzyme active sites.
■ INTRODUCTION
Pyridoxal-5′-phosphate (PLP; Scheme 1) acts as a cofactor in a
large family of enzymes involved in the metabolism of amino
acids and other amine-containing biomolecules.1−4 This single
cofactor can participate in a diverse array of chemical
transformations, including racemization, transamination, α/β-
decarboxylation, and α/β/γ-elimination and substitution, yet
the factors that fine-tune PLP for a specific reaction have yet to
be fully delineated.5−8 While stereoelectronic considerations
play a clear role in directing the first step of catalysis,9 the
majority of PLP-dependent transformations are initiated by the
same α-deprotonation step, so additional specificity must be
conferred during subsequent stages.5−7 Studies of model PLP
compounds show the important function of both protonation
states and tautomerization in modulating chemical reactiv-
ity.8,10−13 In enzymes, it has been proposed that the active-site
residues interacting with the cofactor establish the appropriate
chemical and electrostatic environment to favor a particular
protonation state and a corresponding reaction pathway.5,7,8
Here, we critically test this hypothesis by determining the
protonation states of a carbanionic/quinonoid intermediate in
the β-subunit active site of the PLP-requiring enzyme
tryptophan synthase (TS, EC 4.2.1.20).
The canonical mechanism for PLP-dependent enzyme
catalysis, first proposed to explain the reaction that occurs in
aminotransferase enzymes, relies on the intrinsic property of
quinonoid species to function as electron sinks to effect bond
cleavage and formation in the reacting amino acid moieties.1,14
Scheme 2 highlights the initial mechanistic steps common to all
PLP-dependent enzymes that undergo α-deprotonation.7,15 In
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Scheme 1. Pyridoxal-5′-phosphate
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the resting holoenzyme form, the cofactor is bound via a Schiff
base linkage to the ε-nitrogen of a lysine side chain (the
internal aldimine state, E(Ain)). In the first step of the catalytic
cycle, an incoming amino acid substrate makes a nucleophilic
attack at C4′ of the internal aldimine Schiff base, displacing the
covalent bond between the enzyme and the cofactor and
replacing it with a Schiff base linkage between the substrate and
PLP (the external aldimine species, E(Aex)). Next, a base
abstracts the substrate Cα proton, forming a carbanionic
intermediate that is resonance-stabilized through charge
delocalization.7,14 This intermediate is generally referred to as
the quinonoid intermediate (E(Q)) due to its quinone-like
resonance structure. In practice, the quinone resonance form
can only contribute significantly to the ground-state electronic
structure when the pyridine ring nitrogen is protonated (the
canonical/true quinonoid form). Experimental support for the
formation of a true quinonoid intermediate comes from UV/vis
spectroscopy, which shows a characteristic absorption in the
460−550 nm range,14,16,17 and X-ray crystallography, which
identifies acidic residues hydrogen bonded to the pyridine
nitrogen in several large classes of PLP-dependent enzymes;
these residues are expected to form ion pairs with a protonated
pyridine ring nitrogen.18−22
Recently, the requirement to move through a canonical
quinonoid intermediate in all PLP-dependent enzymes has
been called into question.7,23−25 Several groups have put
forward the hypothesis that in certain cases the intermediate
that forms is not a true quinonoid, but rather a carbanionic
speciesthe chief distinction again being whether the pyridine
ring nitrogen is protonated and can thus support significant
quinone character.7,26−28 This hypothesis is supported by
structural studies of several PLP-dependent enzymes that find
hydrogen-bonding interactions between the pyridine ring
nitrogen and side chains of polar, nonacidic residues, such as
serine, and positively charged residues, such as arginine.29−32
These side chains are not logical proton donors for conversion
to the canonical quinonoid structure. Yet due in part to the
paucity of atomic-resolution structural data (neither X-ray
crystallography nor UV/vis spectroscopy can directly identify
proton locations), the obligatory formation of canonical
quinonoid intermediates has remained the dominant view of
PLP catalysis.33,34
A growing number of solid-state nuclear magnetic resonance
(SSNMR) studies have shown the essential role that NMR can
play in the atomic-resolution characterization of chemical
structure for intermediates and intermediate analogues in PLP-
dependent enzymes.8,35−41 In particular, 15N SSNMR chemical
shift measurements of the pyridine ring nitrogen in the internal
aldimine form of aspartate aminotransferase confirm that at the
start of catalysis the pyridine nitrogen is protonated and ready
Scheme 2. α-Deprotonation and Quinonoid Resonance Forms7
Scheme 3. Tryptophan Synthase β-Site Reaction
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to assist in the formation of a canonical quinonoid
intermediate.8 This is in contrast to the neutral pyridine
nitrogen found by SSNMR in the resting internal aldimine
forms of tryptophan synthase and alanine racemase.8,36
However, in the case of TS, the pyridine nitrogen interacts
with the hydroxyl group of a serine residue.29 The serine
hydroxyl can act as both a hydrogen-bond donor and acceptor,
and it is unclear whether the pyridine ring nitrogen becomes
protonated as the reaction unfolds, thus assuming the canonical
quinonoid form, or if a carbanion is formed that is stabilized by
a combination of charge delocalization and electrostatic
interactions involving other atoms in the site. To date, there
have been no reports of PLP nitrogen chemical shift
measurements for any quinonoid/carbanionic intermediate.
Here, we report SSNMR chemical shifts for a carbanionic/
quinonoid intermediate in the S. typhimurium tryptophan
synthase β-subunit active site, including the first such
measurement for a PLP cofactor pyridine ring nitrogen. The
TS bienzyme complex catalyzes the final two steps in the
production of L-Trp in bacteria, molds, yeasts, fungi, and
plants.42−45 This biosynthetic process requires that the
substrates indole and L-Ser come together in a multistage β-
elimination and replacement reaction (Scheme 3). The
mechanism of action occurs in two stages, elimination of the
L-Ser hydroxyl to give the α-aminoacrylate intermediate,46 and
nucleophilic addition of indole to give the product L-Trp.42
There are several intermediates formed during the β-reaction
that can be rendered quasi-stable through the choice of
monovalent cation47 and α-site ligand,48 control of pH,49 and
introduction of indole analogues.35,50 In this work, we
interrogate the active-site complex formed by the reaction of
L-Ser and 2-aminophenol (2AP) with the PLP-cofactor in
TS.36,51 This intermediate, termed the 2AP-quinonoid (E-
(Q3)2AP, Scheme 4), is a long-lived analogue of the transient
E(Q3) in Scheme 3, allowing for measurement of the PLP
pyridine ring nitrogen chemical shift and additional 13C, 15N,
17O, and 31P isotropic and anisotropic chemical shifts on the
cofactor, substrates, and active-site side chains. Several of the
key chemical shifts, including that for the PLP pyridine
nitrogen, are found to fall outside the ranges anticipated based
on model compound studies. To interpret these shifts in terms
of the protonation states of the intermediate, we turn to “NMR
crystallography”, the combination of X-ray diffraction and solid-
state NMR spectroscopy with computational chemistry.52−56
NMR crystallography was initially introduced as a way to refine
three-dimensional structures of crystalline molecular solids,57
using agreement between first-principles predicted and
experimental chemical shifts as a convergence criterion. This
method has recently been applied to ordered and disordered
extended solids54,55 and to biological systems,35,58−61 including
work by our group and others on enzyme active sites.35,58,61 For
the TS 2AP quinonoid analogue, NMR crystallography
provides direct, atomic-resolution support for the carbanionic
form of the intermediate, ruling out a true quinonoid species
and suggesting an equilibrium between the phenolic and
protonated Schiff base tautomers that favors the phenolic form.
Natural bond orbital (NBO) calculations show the buildup of
negative charge at the substrate Cα for the protonated Schiff
base form, implicating it as the catalytically significant tautomer.
This is consistent with the proposed role of protonation states
in directing reaction specificity in tryptophan synthase and
points to the vital contribution that NMR crystallography can
make to linking both atomic-resolution structure and chemical
dynamics to enzyme mechanism.
■ EXPERIMENTAL SECTION
Protein Preparation. Tryptophan synthase was prepared by
overexpression of S. typhimurium TS in E. coli as previously
described.36,37 Samples were prepared with the following isotopic
labeling schemes for the cofactor and protein components: (1) protein
and cofactor unlabeled/natural abundance isotopomer concentration;
(2) protein 15N-labeled at lysine ε-nitrogen sites; PLP unlabeled
(ε-15N-Lys TS); (3) PLP cofactor selectively 13C enriched at carbon
sites C2, C2′, and C3 and 15N enriched at the pyridine ring nitrogen;
protein unlabeled (2,2′,3-13C3,15N-PLP; TS); and (4) PLP cofactor
selectively 13C,15N enriched; protein uniformly 15N-labeled
(2,2′,3-13C3,15N-PLP; U-15N TS).
Synthesis of Isotopically Labeled PLP and 2AP.
2,2′,3-13C3,15N-Pyridoxal-5′-phosphate was prepared and exchanged
into the β-subunit active site as previously reported.36,62 2-Amino-
phenol was prepared 15N labeled (15N-2AP) following literature
protocols63,64 as described in the Supporting Information.
Microcrystalline Protein Samples for Solid-State NMR.
Microcrystalline samples of TS were prepared by diluting enzyme
solution 1:1 with 50 mM Cs-bicine buffer, pH 7.8, containing 14%
PEG-8000 and 3.0 mM spermine as previously described.36 Micro-
crystals were collected and washed with 50 mM Cs-bicine, pH 7.8,
containing 8% PEG-8000, 1.5 mM spermine, and 3 mM N-(4′-
trifluoromethoxybenzenesulfonyl)-2-aminoethyl phosphate (F9; a high
affinity alpha site ligand and analogue of the natural α-site substrate 3-
idole-D-glycerol-3′-phosphate (IGP)). The crystals were packed at
10 000 rpm into a Bruker 4 mm magic-angle spinning (MAS) rotor
with an approximate volume of 80 μL; each rotor contained 25−30 mg
of protein. To form the 2AP quinonoid intermediate, serine was
introduced by direct addition of 5 μL of 1.2 M L-Ser to the packed
MAS rotor, while 2AP was introduced by addition of 8 μL of a
concentrated stock solution of 2AP in acetonitrile. Stabilization of the
2AP quinonoid species is enhanced by low temperature (−5 °C), the
use of the tight binding α-subunit ligand F9, and the presence of Cs+,48
which binds to the monovalent cation site in the β-subunit.
NMR Spectroscopy. 13C and 15N Solid-State NMR Spectroscopy.
13C and 15N cross-polarization (CP) magic-angle-spinning (MAS)
experiments were performed at 9.4 T (400.37 MHz 1H, 100.69 MHz
13C, 40.57 MHz 15N) on a Bruker AVIII spectrometer equipped with a
double resonance, 4 mm MAS probe, spinning at MAS rates of 8 kHz
(standard) and 2 kHz (slow MAS); the bearing gas was cooled to −15
°C (standard) and −10 °C (slow MAS), giving an effective sample
temperature of ∼−5 °C in both cases. Cross-polarization was
accomplished at a 1H spin-lock field of 45 kHz and a 13C/15N spin-
lock of 54 kHz (13C) and 37 kHz (15N) (ramped ±2 kHz); 85 kHz
Spinal64 1H decoupling65 was used throughout. Standard 13C spectra
consist of the sum of 16 384 transients acquired with a relaxation delay
of 4 s, for a total acquisition time of 18.3 h; slow MAS spectra consist
of the sum of 122 880 transients acquired with a relaxation delay of 4 s,
for a total acquisition time of 5 d 16 h. 13C chemical shifts were
referenced indirectly to neat TMS via an external solid-state sample of
adamantane with the downfield-shifted peak set to 38.48 ppm.66,67
Standard 15N spectra consist of the sum of 81 920 transients acquired
Scheme 4. Formation of the 2AP Quinonoid Intermediate
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with a relaxation delay of 4 s, for a total acquisition time of 3 d 19 h;
slow MAS spectra consist of the sum of 96 304 transients acquired
with a relaxation delay of 4 s, for a total acquisition time of 4 d 13 h.
15N chemical shifts were referenced indirectly to liq-NH3 (25 °C) via
an external solid-state sample of 15NH4Cl, in which the resonance
frequency was set to 39.27 ppm.66,68
The acquisition of solid-state NMR spectra was interleaved with
single pulse, low-power decoupling experiments (64 scans 13C, 256
scans 15N) reporting predominantly on free ligand and reaction
products in solution (mother liquor). Acquisition of solid-state NMR
spectra for the intermediate was halted before reactant concentrations
in solution fell to zero.
31P Solid-State NMR Spectroscopy. 31P CPMAS experiments were
performed at 9.4 T (400.37 MHz 1H, 162.07 MHz 31P) on a Bruker
AVIII spectrometer equipped with an 1H−X double resonance 4 mm
MAS probe, spinning at a MAS rate of 2 kHz. The bearing gas was
cooled to −10 °C, giving an effective sample temperature of −5 °C.
Cross-polarization was accomplished with a 1H spin-lock field of 45
kHz and a 31P spin-lock of 47 kHz (ramped ±5 kHz); 58 kHz Spinal64
1H decoupling65 was used during detection. The 31P spectra consist of
the sum of 24 576 transients acquired with a relaxation delay of 3 s, for
a total acquisition time of 21 h. 31P chemical shifts were indirectly
referenced to 85% H3PO4 (MAS). For comparison to measurements
in solution, δ[85% H3PO4 (capillary)] = δ[85% H3PO4 (sphere/
MAS)] + 0.36 ppm.69
15N-Observe, 31P-Dephased Rotational Echo Double Resonance
Experiments. 15N{31P}-REDOR70 experiments were performed at
14.1 T (600.11 MHz 1H; 60.81 MHz 15N; 242.93 MHz 31P) on a
Bruker AVANCE 600 spectrometer equipped with an NHMFL low-E,
triple resonance 3.2 mm MAS probe71 (sample volume ∼40 μL) and
spinning at a MAS rate of 8 kHz. The bearing gas was cooled to −15
°C, giving an effective sample temperature of −5 °C. Cross-
polarization was accomplished at a 1H spin-lock field of 45 kHz, 15N
spin-lock of 37 kHz (ramped ±2 kHz), and a 2 ms contact time; 100
kHz Spinal64 1H decoupling65 was used throughout. A single 10 μs π
pulse was applied to 15N at the center of the 25 ms echo period, while
a series of 10 μs π pulses at half rotor intervals were applied to 31P
during the dephasing (S) experiments. The REDOR S and So spectra
were acquired in an interleaved fashion, and each spectrum consists of
the sum of 12 288 transients acquired with a relaxation delay of 3 s, for
a total acquisition time of 10.4 h.
Chemical Shift Anisotropy (CSA) Tensor Analysis. Chemical shift
anisotropy tensor principal axis components were determined by a fit
of the sideband intensities in the slow MAS spectra using Herzfeld−
Berger analysis,72 implemented within Bruker BioSpin’s Topspin 3.0
processing software.
X-ray Crystallography. The X-ray crystal structure of the
tryptophan synthase 2AP quinonoid intermediate analogue with Cs+
bound to the monovalent cation site and N-(4′-trifluoromethox-
ybenzenesulfonyl)-2-aminoethyl phosphate (F9) bound to the α-site
was solved at 1.45 Å resolution and previously reported.51 The PDB
accession code is 4HPJ.
First-Principles Calculations. First-principles calculations were
performed on a truncated model of the active site using a cluster-based
approach described previously.73 The cluster was constructed from the
TS 2AP quinonoid crystal structure coordinates (PDB ID: 4HPJ) by
selecting all atoms within 7 Å of the PLP cofactor and covalently
bound serine/2AP substrates (Figure 1a,b).51,73 This selection was
expanded to include complete residues that extended beyond the 7 Å
range. To reduce the total number of atoms while keeping intact
continuous segments of backbone and important side chains at the
periphery of the cluster, the structure was modified as follows: (1)
residues that were not part of continuous backbone segments and with
only one atom within the initial 7 Å cut were deleted (β-site residues
A108, M134, Q142, N145, K167,Y186, M187, V201, I238, S308, L349,
N375, and L376); (2) residues with two backbone atoms and no side
chain residues within 7 Å were converted to alanine (β-site R379); (3)
residues having two side chain atoms and no backbone atoms within 7
Å were truncated by removing the backbone atoms (β-site residues
F280 and H313); (4) N-terminal nitrogen atoms were replaced with a
hydrogen atom and C-terminal carbonyls were capped with an −NH2
group (amidated); (5) the Cs+ cation was replaced with Na+; and (6)
hydrogen atoms were added. The final cluster (Figure 1b) had a total
of 613−617 atoms, depending on the protonation state of the
cofactor−substrate complex.
The active site cluster was used as a framework for building models
of the enzyme-bound intermediate with different protonation states.
Thirty candidate structures were generated by systematically varying
the protonation states of the following seven ionizable sites that lie on
or near the PLP−ligand complex (Figure 1c): the ε-amino group of
βLys87; the PLP phosphate group; the pyridine nitrogen; the
pyridoxal phenolic oxygen; the Schiff base nitrogen; and both
carboxylate oxygen atoms. On the basis of its CSA tensor (vide
infra), the phosphate group was taken to be dianionic. Models that had
more than a single proton placed at either the pyridoxal oxygen, the
Schiff base nitrogen, or the closest carboxylate oxygen were not
considered; doubly protonated carboxylates were also excluded. The
models were labeled using a binary code to indicate whether a site was
protonated (“1” − yes, “0” − no) in the following order: (Nε of
βLys87) (phosphate group)-(pyridine nitrogen)-(pyridoxyl phenolic
oxygen) (Schiff base nitrogen)-(nearer carboxylate oxygen to the
Schiff base) (farther carboxylate oxygen); these sites are designated as
AB-C-DE-FG in Figure 1c. Using this nomenclature, the species in
Figure 1c is labeled 10-0-10-00. Four structures given additional
shorthand labels were the carbanionic intermediate with a protonated
phenolic oxygen (10-0-10-00, C-Phen), the carbanionic intermediate
with a protonated Schiff base (10-0-01-00, C-PSB), the quinonoid
intermediate with protonated phenolic oxygen (10-1-10-00, Q-Phen),
and the quinonoid intermediate with a protonated Schiff base (10-1-
01-00, Q-PSB) (Schemes 5 and 6).
All models were geometry optimized in Gaussian 0974 at the DFT
B3LYP level of theory using a two-tier, locally dense basis set with 6-
31G(d,p) for the PLP/substrate complex and 6-31G for all other
atoms. Atoms on or within 4 Å of the PLP/substrate complex and all
hydrogen atoms in the cluster were allowed to adjust, while the
remaining atom coordinates were fixed at their crystallographic values.
In general, the optimized coordinates differed by less than 0.1 Å
Figure 1. (a) X-ray crystal structure of the tryptophan synthase α2β2
heterodimer, highlighting the β-subunit active site in red. (b) Cluster
model of the β-subunit active site for first-principles geometry
optimization and chemical shift calculations. Protein side chains are
shown in wireframe, and the cofactor and substrates are in ball-and-
stick. (c) Potential sites of protonation on and near the cofactor/
substrate complex include (A) the βLys87 side chain, (B) the PLP
phosphate group, (C) the PLP pyridine ring nitrogen, (D) the PLP
phenolic oxygen, (E) the Schiff-base nitrogen, and (F,G) the substrate
carboxylate. Shaded nuclei indicate sites for which experimental NMR
chemical shifts are reported.
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RMSD from the initial coordinates, with the largest movements on the
order of 0.2 Å. Still, the refinement step was considered essential as
first-principles computational refinements of crystal coordinates have
been shown to give higher accuracy prediction of chemical shifts, even
for molecular crystals with neutron diffraction structures available.75
The ability to perform this optimization on larger clusters using full
DFT refinement is a significant improvement over our earlier
implementation.35
NMR shieldings were calculated for the optimized structures using
the Gauge Independent Atomic Orbital (GIAO) method at the DFT
B3LYP level of theory and employing a three-tier, locally dense basis
set assignment with the PLP/substrate atoms at 6-311+G(2d,p),
atoms within 4 Å of the PLP/substrate complex at 6-311G(d,p), and
all remaining atoms at 6-31G. NMR shielding (σ) values were
converted to chemical shifts (δ) using the following linear rescaling
relationships calibrated at the same level of theory and bases:76,77
δ σ= − +C: [TMS(l)] ( 0.9685) 173.7013 calc (1)
δ δ
σ
= +
= − +
N: [NH (l)] [NH Cl(s)] 39.27
( 0.9996) 230.45
15
3 4
calc (2)
δ σ= − +O: [H O(l)] ( 1.0551) 266.3217 2 calc (3)
Previously reported benchmark studies applying these rescaling
relations across test sets of solid-state structures gave root-mean-
square errors (RMSE) for isotropic shifts of 1.5 ppm for 13C, 4.3 ppm
for 15N, and 7.5 ppm for 17O,76 and an RMSE for 13C chemical shift
tensor components of 4.2 ppm.77 In the analysis below, the RMSE for
15N chemical shift tensor components was approximated as 13.7 ppm,
which maintains the ratio of RMSE for 13C and 15N isotropic and
anisotropic shifts.
The structural models were ranked based on the agreement
between their first-principles predicted chemical shifts and the
experimental NMR parameters using the reduced-χ2 statistic:78
∑χ δ δ= −
−
N f s
(model)
1 ( )
i
i i
i
r
2
model exp 2
2
(4)
Here, N is the number of chemical shifts measured, f is the number of
adjustable model parameters (0 for the direct ranking of models; 1 for
the exchange model with optimized populations), δi
exp is the
experimental chemical shift, δi
model is the corresponding predicted
shift for a given model, and si
2 is the nuclide-specific weighting derived
by setting si to the corresponding root-mean-square error derived from
benchmark studies. For properly assigned weights, the reduced-χ2
should approach 1 for a large number of measured chemical shifts. For
a finite number of experimental values, the reduced-χ2 may be larger
(or smaller) due to sampling statistics. For the 12 experimental
isotropic chemical shift measurements here, models with reduced-χ2
greater than 1.75 can be ruled out with better than 95% confidence.78
Natural bond orbital (NBO) partial atomic charges were calculated
for the geometry-optimized clusters using natural population analysis79
within the NBO 6.0 program.80 These calculations were performed on
the same clusters and at the same level of theory and basis set
assignments used for the NMR calculations.
■ RESULTS AND DISCUSSION
15N Chemical Shift Measurements. Figure 2 shows 15N
solid-state NMR spectra of the tryptophan synthase 2AP
quinonoid intermediate prepared under the following five
isotopic-labeling conditions: (2a) natural abundance iso-
topomer concentration; (2b) selectively 13C,15N enriched on
the PLP cofactor (2,2′,3-13C3,15N-PLP; TS); (2c) 15N-enriched
on the L-Ser substrate; (2d) 15N-labeled on the 2AP substrate;
and (2e/2f) selectively 15N-enriched at all protein lysine ε-
nitrogen side chain sites (ε-15N-Lys TS). The spectrum
acquired at natural abundance (Figure 2a) shows primarily
signals from the large number of protein backbone nitrogen
atoms; these are centered near 122 ppm. With the
incorporation of the isotopically enriched PLP cofactor, a
new spectral feature at 262.0 ppm is observed that can be
assigned to the pyridine ring N1 atom (Figure 2b). This
chemical shift immediately presents a puzzle: a protonated
pyridine nitrogen would be expected to fall below 200 ppm,
while the signal for a deprotonated pyridine nitrogen should be
greater than 300 ppm.10,13 Negligible temperature dependence
is found for the PLP nitrogen chemical shift (Figure 3a), which
together with the narrow line width argues against proton
exchange as the source of the intermediate shift value. Pyridine
ring nitrogen chemical shifts in this range have been observed
for model PLP−aldimine complexes that participate in strong
hydrogen bonds with carboxylic acids.8 Yet an upfield shift of
this magnitude would require a significant displacement of the
proton toward the center of the OHN bond, and it is unclear
whether such a strong hydrogen bond could form between the
pyridine ring nitrogen and its partner, the side-chain hydroxyl
of βSer377.
Figure 2c shows the spectrum of the 2AP quinonoid
prepared using 15N-enriched L-Ser, which introduces an 15N
isotopic label at the Schiff base position. At 298.6 ppm, the
chemical shift of this site is indicative of a (mostly) neutral
imine. Variable temperature experiments show a more
substantial chemical shift temperature dependence for the
Schiff-base nitrogen (−0.07 ppm/K; Figures 3a, S1), suggesting
that this site may be participating in chemical exchange. Figure
S2 shows the same sample under slow (2 kHz) MAS that
allows the three CSA tensor principal axis components, {δ11,
δ22, δ33} = {526.8, 368.6, 0.3} ppm, to be extracted. The
corresponding anisotropy, δzz − δiso = −298.3 ppm, is
somewhat attenuated (and has opposite sign) compared to
model compound studies of fully deprotonated Schiff base
nitrogen sites.81 Figure 2d shows the spectrum of the
Scheme 5. Carbanionic Phenolic and Protonated Schiff Base
Tautomers with NBO Partial Charges Indicated at Cα and
C4′
Scheme 6. Quinonoid Phenolic and Protonated Schiff Base
Tautomers with NBO Partial Charges Indicated at Cα and
C4′
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intermediate prepared using 15N-labeled 2AP. The chemical
shift of 56.0 ppm for the amine linkage helps establish that the
connection from serine to 2AP is through the amino rather
than the 2AP phenolic group, a fact that cannot be determined
directly from crystallography. This bond is confirmed by 2D
nitrogen−carbon correlation spectroscopy for the intermediate
prepared using both 15N-labeled 2AP and 3-13C-Ser (Figure
S3).
To determine the charge state of the active-site, catalytic
βLys87 side chain, a protein sample was prepared in which all
lysine residues were 15N-enriched at the ε-nitrogen sites (ε-15N-
Lys TS). The spectrum of this sample (Figure 2e) shows a large
number of mostly overlapped resonances centered at 33 ppm.
These correspond to charged ε-amino groups on the labeled
lysine residues, and presumably βLys87 is among them. We
previously reported that the βLys87 amino group is neutral and
resonates at 24.2 ppm in the TS aminoacrylate intermediate,
and the addition of 2AP to form the quinonoid correlates with
the loss of this resonance.37 These data suggest that upon
moving from the aminoacrylate to the 2AP quinonoid form, the
βLys87 side chain switches from neutral to positively charged,
consistent with the proposed mechanism in which βLys87 plays
alternating acid and base roles.37 To directly observe the
βLys87 resonance, we take advantage of the fact that it is the
only lysine residue within the active site and the only lysine
with close spatial proximity to the phosphate group of PLP; the
crystal structure shows that βLys87 and the cofactor phosphate
are hydrogen bonded with a distance of 3.7 Å between the PLP
phosphorus atom and the side chain ε-nitrogen (PDB ID:
4HPJ). The other 26 lysines in the TS αβ-dimer are located on
the exterior of the protein, and none is closer than 11.1 Å to the
PLP phosphorus or 9.5 Å to the F9 phosphorus (the only other
phosphorus atom present in the complex). This allows for
observation of βLys87 using 15N-observe,31P-dephased rota-
tional-echo double-resonance70 (15N{31P}-REDOR) difference
experiments (Figure 2e,f). These experiments selectively edit
out 15N resonances that are strongly dipolar coupled, and
therefore close in space, to a phosphorus atom. The spectra in
Figure 2e and f form a REDOR pair; each has a 25 ms echo
period on 15N before detection, but Figure 2f includes the
application of dipolar dephasing to 31P. There is a single
resonance at 31.5 ppm that is selectively attenuated. Based on
Figure 2. 15N SSNMR CPMAS spectra of the microcrystalline TS 2AP
quinonoid intermediate prepared with the following isotopic labeling:
(a) natural abundance isotopomer concentration; (b) selectively
13C,15N enriched on the PLP cofactor; (c) 15N-enriched on the
substrate L-Ser; (d) 15N-labeled on the substrate 2AP; and (e,f)
selectively 15N-enriched at lysine ε-nitrogen side chain sites. Spectra
(e) and (f) form an 15N{31P}-REDOR pair; both have a 25 ms echo
period on 15N before detection, but (f) includes the application of
dipolar dephasing to 31P. Their difference spectrum (Δ) allows for the
selective observation of Nε for the active site lysine side chain. Spectra
acquired at 9.4 T (a−d), 14.1 T (e,f), and 8 kHz MAS; additional
experimental details are given in the main text.
Figure 3. Variable-temperature 15N and 13C CPMAS spectra of the
microcrystalline TS 2AP quinonoid intermediate prepared with
2,2′,3-13C3,15N-PLP, 15N-Ser, and U-15N-TS. (a) Substantial temper-
ature dependence is observed for the Schiff base nitrogen (blue dot).
The large spectral feature at 330 ppm is a spinning sideband of the
labeled amide backbone. (b) Temperature dependence is also
observed for the PLP C3 site (red dot), which shows a resolved
scalar coupling to C2. Spectra acquired at 9.4 T and 8 kHz MAS;
additional experimental details are given in the main text.
Journal of the American Chemical Society Article
DOI: 10.1021/jacs.6b08937
J. Am. Chem. Soc. 2016, 138, 15214−15226
15219
proximity to the phosphate group, this resonance is assigned to
the ε-amino group of βLys87, confirming its charged state.
13C Chemical Shift Measurements. Figure 4 shows 13C
solid-state NMR spectra of the tryptophan synthase 2AP
quinonoid intermediate prepared under the following three
isotopic labeling conditions: (4a) natural abundance iso-
topomer concentration; (4b) selectively 13C,15N enriched on
the PLP cofactor (2,2′,3-13C3,15N-PLP TS); and (4c)
U-13C3,
15N-enriched on L-Ser. Considerably more background
signals are observed at 13C natural abundance (1.1%) compared
to 15N (0.36%) (Figure 4a). In Figure 4b, the incorporation of
isotopically 13C-enriched PLP leads to three new resonances at
17.0, 144.6, and 153.1 ppm; on the basis of their chemical shifts
and J-coupling patterns (Figure 3b), these are assigned to C2′,
C2, and C3 of PLP, respectively. The C2 and C3 shifts are
important for establishing the charge state of the PLP phenolic
oxygen, and comparison to model compound studies by
Harruff and Jenkins82 and O’Leary and Payne83 indicates a
protonated phenolic oxygen on PLP. These shifts can be
contrasted with those for the TS internal aldimine, which fall at
158.4 and 168.6 ppm for C2 and C3, respectively,36 values
consistent with the zwitterionic form in which the phenolic
oxygen is deprotonated. Figure 3b shows that C3 has a slight
temperature dependence of +0.012 ppm/K for the 2AP
quinonoid intermediate, moving downfield away from the
protonated, phenolic form and toward the deprotonated,
phenolate form.
The spectrum in Figure 4c, measured for the intermediate
formed with U-13C3,
15N-L-Ser, shows three new resonances at
173.1, 105.1, and 47.0 ppm that can be assigned to carbons that
derive from the serine C′, Cα, and Cβ, respectively. These shifts
are similar to those reported for the TS quinonoid formed with
indoline.35 While both the Cα and the Cβ chemical shifts for the
covalently bound substrate are distinct from those of the free
substrate (57.4 and 61.3 ppm, respectively), the C′ shifts are
quite similar. The assignment of C′ was therefore verified using
through-bond (J-based) 2D 13C correlation spectroscopy84
(Figure S4). Figure S5 shows the 13C SSNMR spectrum for the
2AP quinonoid formed with 13C′-Ser and acquired at a MAS
rate of 2 kHz. Again, the full CSA tensor can be extracted from
a fit of the sideband intensities, giving principal axis
components {δ11, δ22, δ33} = {209.3, 204.7, 105.2} ppm. The
δ11 and δ22 tensor components differ markedly from model
compound studies of solid-state amino acids,85−87 but are
known to depend critically on hydrogen-bonding interactions.
These values presumably reflect the unique electronic environ-
ment of the carbanion/quinonoid intermediate and the
distinctive hydrogen-bonding arrangements within the carbox-
ylate binding pocket.
31P Chemical Shift Measurements. The 31P solid-state
NMR spectrum of the tryptophan synthase 2AP quinonoid
intermediate is shown in Figure 5. The paired resonances
correspond to the two phosphate groups of PLP and the high-
affinity α-site ligand F9. Samples prepared without F9 confirm
the assignment of the downfield shifted isotropic peak
(designated by the arrow) to PLP. Under the slow MAS
conditions (2 kHz) used here, both its isotropic and anisotropic
shift components can be determined and are found to be δiso =
4.9 ppm and {δ11, δ22, δ33} = {56.8, −7.1, −35.0} ppm,
respectively. The PLP cofactor isotropic shift shows a
characteristic response in solution as the phosphate moves
from the mono- to the dianionic form.88 The isotropic shift in
the 2AP quinonoid places it in the dianionic regime. It has been
noted that the anisotropy of the tensor (whether the manifold
of sidebands peaks to the left or to the right) may be a better
indicator of charge state for a phosphate group in a protein
environment.89,90 Like the isotropic shift, the anisotropy has
been shown to switch as the phosphate group changes
protonation state. Here, the anisotropy δzz − δiso = 51.9 ppm
agrees well with the dianionic form of model PLP compounds.
The phosphate group on F9 is also dianionic, with δiso = 3.6
ppm, {δ11, δ22, δ33} = {66.3, −11.0, −44.6 } ppm, and δzz − δiso
= 62.8 ppm.
Figure 4. 13C SSNMR CPMAS spectra of the microcrystalline TS 2AP
quinonoid intermediate prepared under (a) natural abundance
isotopomer concentration; (b) selectively 13C,15N-enriched on the
PLP cofactor; and (c) U-13C3,
15N-enriched on the substrate L-Ser.
Spectra acquired at 9.4 T and 8 kHz MAS; additional experimental
details are given in the main text.
Figure 5. 31P SSNMR CPMAS spectrum of the microcrystalline TS
2AP quinonoid intermediate acquired at 9.4 T and 2 kHz MAS. The
PLP phosphate group isotropic peak at 4.9 ppm is indicated by the
arrow and that from F9 with the asterisk. A fit (red) to the sideband
manifold in BrukerTopspin 3.0 allows for the extraction of the CSA
principal axis components {δ11, δ22, δ33} = {56.8, −7.1, −35.0} ppm for
the PLP phosphate group and {δ11, δ22, δ33} = {66.3, −11.0, −44.6}
ppm for F9. The order of the spinning sidebands is given above each
peak.
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17O Chemical Shift Measurements. Recently, we
reported solution-state 17O NMR chemical shifts for the L-Ser
derived carboxylate oxygen atoms for the 2AP quinonoid.91
The isotropic chemical shifts are nearly identical, falling at 237
and 239 ppm. For comparison, the isotropic chemical shifts of
carboxylate oxygens in amino acids typically range from 250 to
314 ppm in the solid state.92 Oxygen chemical shifts are
sensitive to both the number and the relative strength of
hydrogen-bonding interactions, and the large chemical shift
range in both solids and proteins reflects the diversity of
hydrogen-bonding environments encountered.92,93 For exam-
ple, the isotropic shifts for the two oxygen atoms in the TS
aminoacrylate intermediate are resolved and fall at 258 and 292
ppm.91 In contrast, ionized carboxylates in aqueous solution
(mid to high pH) exhibit a much narrower chemical shift range
of 264−271 ppm, due to a dynamic averaging of the hydrogen-
bonding environment, while protonated carboxylic acid forms
prepared in solution at low pH show a single oxygen resonance
in the range of 250−255 ppm, corresponding to an average of
the hydroxyl and carbonyl oxygen shifts under fast proton
exchange.94 Like the pyridine ring nitrogen chemical shift, the
oxygen chemical shifts for the 2AP quinonoid intermediate do
not lend themselves to a straightforward interpretation.
Protonation States of the 2AP Quinonoid Intermedi-
ate from NMR Crystallography. Taken together, the
chemical shifts for the 2AP quinonoid intermediate (summar-
ized in Tables 1 and 2) allow a preliminary model to be
proposed for the protonation states on and near the cofactor−
substrate complex in the active site of tryptophan synthase.
With good confidence, it can be concluded that the phosphate
group is dianionic and the βLys87ε-amino group is positively
charged. At the same time, the 15N chemical shift of the Schiff
base nitrogen, coupled with the PLP C2 and C3 shifts, point to
an intermediate in its phenolic form, with a neutral Schiff base
linkage to substrate. However, the Schiff base nitrogen shift is
somewhat lower than that of deprotonated imine model
compounds.8,81 The temperature dependence of the chemical
shifts for both the Schiff base nitrogen and the PLP C3 is away
from the phenolic form and toward the protonated Schiff base
form, suggesting a fast tautomeric exchange between these two
species. The intramolecular hydrogen bond in model PLP−
Schiff base complexes is known to exhibit proton exchange, and
a two-site model has been proposed by Chan-Hout et al. to
interpret the nitrogen chemical shift in terms of the
corresponding equilibrium constant.8
The chemical shift of the pyridine ring nitrogen at 262.0
ppm, however, remains enigmatic; based on model aldimine
complexes, a deprotonated PLP nitrogen would be expected to
fall above 300 ppm, and a protonated pyridine nitrogen below
200 ppm.10,13 As noted above, the narrow resonance and lack
of significant temperature dependence suggest that this shift is
not the result of chemical exchange. Strong hydrogen bonding
to the pyridine nitrogen could effect such a shift, but would
require a stronger hydrogen bond than seems reasonable for
the interaction with the side-chain hydroxyl of βSer377. The
carboxylate oxygen chemical shifts similarly present a puzzle, as
they too fall outside the range expected on the basis of model
compound studies. Interpreting these shifts will require moving
beyond the empirical correlation of chemical shift with
structure to the more quantitative methods of first principles
computational chemistry. Multiple benchmark studies have
demonstrated that if the molecular structure and three-
dimensional geometry are accurately known, it is possible to
very precisely predict solid-state NMR chemical shifts using
first-principles methods.76,95,96 Here, we make use of this
predictive power in the context of NMR crystallography, in
which atomic-resolution models of the active site are built on
the framework of the X-ray crystal structure, and these models
are screened and ranked based on the agreement between their
first-principles predicted chemical shifts and the experimental
NMR parameters.
The application of NMR crystallography to the tryptophan
synthase 2AP quinonoid intermediate requires that three-
dimensional models of the active site first be constructed.
Thirty candidate structures with varying protonation states
(Scheme S1) were systematically generated on the framework
of the X-ray crystal structure, geometry optimized, and their
NMR parameters predicted (Table S1). These candidate
structural models are ranked in Figure 6a based on the
agreement between their predicted and experimental isotropic
chemical shifts using the reduced-χ2 statistic. Although there is
a clear differentiation of models, none of the candidate
structures shows the expected agreement with the experimental
chemical shifts. The best-fit model, with a reduced-χ2 value of
3.4, is for the phenolic tautomer of the carbanionic species
(Scheme 5). Its key chemical shifts are given in Table 1.
Interestingly, this structure reproduces the pyridine ring
nitrogen and carboxylate oxygen chemical shifts quite
accurately, but has a large deviation between the theoretical
and experimental chemical shift for the Schiff base nitrogen
Table 1. Experimental and First-Principles Chemical Shifts
(ppm) for the Carbanionic Phenolic and PSB Forms, and
their Best-Fit Two-Site Exchange
fragment atom C-Phen C-PSB two-site expt
PLP N1 256.9 272.3 259.8 262.0
C2 141.1 149.5 142.7 144.6
C2′ 18.7 20.6 19.1 17.0
C3 150.2 164.2 152.9 153.1
L-Ser SB N 320.5 202.0 297.9 298.6
Cα 107.9 93.2 105.1 105.1
C′ 172.8 170.1 172.3 173.1
Cβ 47.3 47.4 47.4 47.0
O1 239.6 229.9 237.8 239.0
O2 234.3 224.9 232.5 237.0
βK87 Nε 26.6 26.4 26.6 31.5
2AP N 53.8 51.9 53.4 56.0
red. χ2 3.41 53.22 0.52
Table 2. Experimental and First-Principles Chemical Shift
Tensor Principal Axis Components (ppm) for the
Carbanionic Phenolic and PSB Forms, and their Best-Fit
Two-Site Exchange
site comp C-Phen C-PSB two-site expt
Schiff-base N δ11 584.8 348.4 523.0 526.8
δ22 396.1 240.7 383.1 368.6
δ33 −19.4 17.1 −12.3 0.3
red. χ2 7.99 85.84 0.68
C′ δ11 216.3 215.2 216.1 209.3
δ22 200.3 195.5 199.3 204.7
δ33 101.9 99.8 101.5 105.2
red. χ2 1.47 2.77 1.63
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(320.5 ppm vs 298.6 ppm, respectively). This is not entirely
unexpected, as the temperature dependence of this site suggests
tautomeric exchange. We allowed for this possibility by also
considering fast-exchange equilibrium models, in which
tautomers that differed by the position of a single proton
were paired and their populations optimized for best agreement
with the experimental chemical shifts. These models were again
ranked, and the results are shown in Figure 6b. The best-fit,
with a reduced-χ2 of 0.52, is for the exchange between the
carbanionic phenolic (81%) and protonated Schiff-base (19%)
forms (Scheme 5; shifts summarized in Table 1). In this
equilibrium, both exchange partners have a charged βLys87 side
chain. The next best exchange model is between the same
major species, the carbanionic phenolic form, and the acid form
of the substrate, in which the proton has transferred to the
nearer carboxylate oxygen. Yet with a reduced-χ2 of 3.12, this
model can be ruled out with greater than 95% confidence.
Importantly, all models with a protonated pyridine nitrogen can
also be confidently excluded, allowing us to conclude that the
tryptophan synthase 2AP quinonoid intermediate is in fact a
carbanionic species. Although we will still loosely refer to the
intermediate as the “2AP quinonoid”, it should more accurately
be referred to as the “2AP carbanionic intermediate”.
We also considered three-site exchange models and found
that none was able to perform substantially better than the best-
fit two-site exchange. However, it is not possible to strictly rule
out small contributions of other tautomers. Previously, for the
quinonoid intermediate analogue formed with indoline in place
of 2AP, we proposed that the acid form played a significant
role.35 This analysis was based on a limited number of chemical
shifts, however, and the assumption that this intermediate was a
true quinonoid. The protonation states determined for the 2AP
carbanionic intermediate prompted us to reexamine this
analogue and collect additional 13C and 15N SSNMR chemical
shifts for the indoline quinonoid intermediate formed with
labeled PLP (Figures S6 and S7). The PLP 13C and 15N shifts
are nearly identical to those for the 2AP quinonoid, and first-
principles computational analysis again gives a fast-exchange
equilibrium between the carbanionic phenolic (77%) and
protonated Schiff base (23%) tautomers as the best description
of the chemical state (Supporting Information), although small
(1%) contributions from the acid-form cannot be ruled out.
Importantly, the conclusion that the E(Q3) intermediate is in
fact a carbanionic species is confirmed for a second quinonoid
analogue in TS.
For the 2AP carbanionic intermediate, the best-fit equili-
brium model is consistent with the chemical shift temperature
dependence observed for the Schiff base nitrogen (N1) and
PLP C3 resonances. The 81:19 population ratio corresponds to
a free energy difference of +0.78 kcal/mol, and a two-site
exchange model would predict chemical shift temperature
coefficients of −0.099 and +0.012 ppm/K for N1 and C3,
compared to the experimental values of −0.07 and +0.012
ppm/K. The Schiff base nitrogen resonance also shows
narrowing with increased temperature as expected for a system
in fast exchange (Figure S1). A detailed analysis of the
temperature-dependent line shape allows a barrier to proton
exchange of 8.9 kcal/mol to be estimated (Supporting
Information).
As an additional test of the two-site exchange models, the
first-principles chemical shift anisotropy tensors were screened
against the experimental principal axis components. CSA
tensors are particularly sensitive to both protonation state
and dynamics. The reduced-χ2 for the exchange-averaged CSA
tensors are displayed as separate columns in Figure 6b, with the
population weightings determined by the isotropic shift models
alone, so there are no adjustable parameters in these
comparisons. While many of the models show reasonable
agreement for the C′ tensor, the Schiff-base nitrogen tensor is
very sensitive to the percent protonation at that site, and the
proposed phenolic-protonated Schiff base exchange model is
again the only one that agrees with the experimental data within
the 95% confidence limits (reduced-χ2 < 2.6 for N = 3; shifts
summarized in Table 2).
Based on the first-principles analysis, it appears that the large
upfield shift of the pyridine ring nitrogen is due in part to the
additional electron density in the conjugated π-bonding system
for the carbanionic intermediate and in part to the hydrogen-
bonding interaction with βSer377. Yet contrary to tentative
speculation, this hydrogen bond is not atypically strong: the
first-principles, geometry-optimized structure for the carba-
nionic phenolic tautomer (C-Phen) shows that the proton is
closely associated with the serine hydroxyl oxygen, with an OH
bond length of 1.02 Å, NO distance of 2.61 Å, and NH distance
of 1.60 Å. The component of the shift that can be specifically
attributed to the hydrogen bond can be estimated via in silico
mutation of βSer377 to alanine and subsequent first principles
calculations (Supporting Information). This mutant gives a
chemical shift of 302 ppm for the non-hydrogen-bonded,
Figure 6. (a) Reduced-χ2 comparing the experimental and first-
principles isotropic chemical shifts for 30 geometry-optimized active-
site models with varying protonation states (structures and labeling
given in Scheme S1). Models with reduced-χ2 greater than 1.75 can be
excluded with over 95% confidence. (b) Reduced-χ2 comparing the
experimental and first-principles isotropic and anisotropic chemical
shifts for the 10 best fast-exchange equilibrium models. For each
optimized isotropic model (red), the corresponding population
weighted CSA tensors are also compared to the experimental principal
axis components for the substrate C′ (gray) and Schiff base N (blue)
sites.
Journal of the American Chemical Society Article
DOI: 10.1021/jacs.6b08937
J. Am. Chem. Soc. 2016, 138, 15214−15226
15222
deprotonated C-Phen pyridine nitrogen. The wild-type C-Phen
NH bond distance of 1.60 Å and upfield shift of 45 ppm relative
to the deprotonated mutant agree fairly well with the
correlation of shift and NH hydrogen-bond length derived by
Limbach et al. for aldimine complexes,13 although care must be
taken to note the different limiting values for the pyridine shift
in the deprotonated forms (321 ppm for aldimines, 302 ppm
for C-Phen). The remaining 20 ppm of the experimental
upfield shift is attributed to the additional electron density in
the conjugated π-bonding system for the carbanionic
intermediate. We also note that the ε-nitrogen chemical shift
of βLys87 appears to track the expected correlation with
protonation state established in aqueous solution.97 In contrast,
the chemical shift of poly-L-lysine (PLL) salts formed with
various acids shows a much wider range of chemical shifts.97 A
priori, there is no reason to expect that lysine residues buried in
the interior of a protein would show the same chemical shift
dependence with ionization state as those exposed to aqueous
solution, yet this appears to be the case experimentally for the
TS active site and is reproduced by our first principles
computational predictions. We note that for TS, the lack of
representative model compounds for active-site intermediates
makes first-principles calculations essential to the interpretation
of their chemical shifts.
Protonation States and Reaction Specificity in
Tryptophan Synthase. The application of NMR crystallog-
raphy to the tryptophan synthase 2AP quinonoid intermediate
allows an atomic-resolution model of the active site to be
established that not only reveals the chemical structure and
protonation states of the cofactor and substrates, but also
reports on charge states and intermolecular hydrogen-bonding
interactions with active site residues (Figure 7). Most
significantly, the 2AP quinonoid intermediate is found to be a
carbanionic species in which the PLP pyridine ring nitrogen is
deprotonated and participates in a (standard) hydrogen bond
with βSer377. At the same time, the catalytic βLys87 side chain
is positively charged and hydrogen bonded to the dianionic
PLP phosphate group. Two additional hydrogen bonds are
formed from βLys87 to βGly189 and the 2AP nitrogen, and
another from the 2AP phenolic group to the carboxylate of
βGlu109. Importantly, this carbanionic intermediate is found to
be undergoing fast proton exchange between its phenolic and
protonated Schiff base tautomers.
These structures and this equilibrium have fundamental
implications for the mechanism in tryptophan synthase. While
traditional views of PLP catalysis maintain the need for a
protonated pyridine nitrogen to stabilize the buildup of
negative charge generated during the reaction, more recent
experimental33,99−101 and theoretical25,27,102,103 considerations
point to a trade-off between the maximum electrophilic
strength offered by a true quinonoid intermediate and reaction
specificity that may be conferred by alternative protonation
states.26 In the case of the TS quinonoid intermediate, E(Q3),
the next step in catalysis requires protonation at the substrate
Cα (Scheme 3). This proton is presumably supplied by the
positively charged ε-amino group of βLys87, which is
positioned nearly equidistant between the cofactor C4′ and
substrate Cα. To maintain reaction specificity, protonation must
be directed away from C4′, the site of protonation for the
competing transamination pathway. Factors that lead to the
buildup of negative charge at Cα and a large charge differential
with C4′ are therefore expected to help direct and maintain
reaction specificity. To delineate the role of protonation states
in this process, atomic partial charges were calculated for the
active site computational clusters using natural population
analysis79 in NBO 6.0.80 Four tautomers were considered: the
exchanging carbanionic phenolic and protonated Schiff base
forms found by NMR crystallography, C-Phen and C-PSB
(Scheme 5), and their canonical quinonoid counterparts, Q-
Phen and Q-PSB (Scheme 6). The resulting NBO charges at
Cα and C4′ are shown in the respective schemes. For C-Phen,
the C4′ and Cα partial charges are both negative and similar in
magnitude, −0.078 and −0.082 au, respectively. Upon transfer
of the proton to the Schiff base nitrogen to give C-PSB, the
charges diverge with Cα becoming more negative, −0.116 au,
and C4′ slightly positive, +0.015 au; this is consistent with the
proposed ylide stabilization of negative charge at Cα for the
PSB form.6 Protonation of the pyridine nitrogen to give the
canonical quinonoid Q-Phen shows a reversal of these trends:
now the phenolic form has C4′ at its most negative value,
Figure 7. Protonation states and hydrogen-bonding interactions revealed by NMR crystallography in the tryptophan synthase β-subunit active site.
The 2AP quinonoid intermediate is found to be a carbanionic species undergoing fast proton exchange between its (a) phenolic (81% occupancy)
and (b) protonated Schiff base (19% occupancy) tautomeric forms. Several of the key hydrogen-bonding interactions to the cofactor and substrate
are indicated, including the (standard) hydrogen bond between the PLP ring nitrogen and βSer377. Images rendered in UCSF Chimera.98
Journal of the American Chemical Society Article
DOI: 10.1021/jacs.6b08937
J. Am. Chem. Soc. 2016, 138, 15214−15226
15223
−0.103 au, and Cα positive at +0.012 au. The protonated Schiff
base tautomer Q-PSB sees the charges at both Cα and C4′
converge to nearly equal values, −0.045 and −0.032 au,
respectively. These results mirror the trends found by
Casasnovas et al.28 on smaller quinonoid intermediate model
systems in implicit solvent. The larger clusters used here (over
600 atoms), however, maintain important intermolecular
interactions between the cofactor and enzyme residues that
appear capable of influencing the overall charge on the
cofactor/substrate complex.
Most critical for understanding mechanism and reaction
specificity in tryptophan synthase, it is the carbanionic
protonated Schiff-base tautomer, C-PSB, that builds up the
largest negative charge at Cα and the greatest charge differential
with C4′. This charge distribution favors protonation at Cα, as
required for the TS β-elimination and replacement reaction,
and disfavors protonation at C4′. The carbanionic phenolic
tautomer, C-Phen, shows minimal charge differential between
Cα and C4′ and provides a less attractive target for protonation.
We therefore propose that C-PSB is the more catalytically
active and important tautomer, despite the fact that it is only
transiently populated by fluctuations (proton exchange) from
the more stable phenolic form. Protonating the pyridine
nitrogen to form the canonical quinonoid intermediate reverses
the relative charges at C4′ and Cα, giving tautomers more likely
to be found on the transamination pathway. These partial
charge calculations help to place the TS 2AP protonation states
in context: although the PLP cofactor in TS is expected to be
less electrophilic due to the deprotonated pyridine ring
nitrogen, it appears that this is an important component in
maintaining reaction specificity by giving a more Cα-localized
carbanionic species.7,26
■ CONCLUSION
The application of NMR crystallography, the highly integrated
combination of solid-state NMR spectroscopy, X-ray crystallog-
raphy, and computational chemistry, to the tryptophan
synthase 2AP quinonoid intermediate provides an atomic-
resolution description of structure, protonation states, and
chemical dynamics that would be impossible to achieve by the
individual application of these techniques. Indeed several of the
key active-site chemical shifts and CSA tensors fall outside of
the range established in model compound studies, and it is only
through first principles calculation of NMR parameters that a
model can be confidently established. This model reveals that
the 2AP quinonoid is in fact a carbanionic species with a
deprotonated pyridine ring nitrogen, and that this intermediate
is undergoing fast proton exchange between its phenolic and
protonated Schiff base tautomeric forms. These results provide
direct experimental support that true quinonoid formation is
not a prerequisite for carbanion stabilization in PLP-dependent
enzymes. Natural bond orbital analysis confirms the catalytic
significance of these protonation states: the buildup of negative
charge for the protonated Schiff base in particular helps to
direct the proton from Nε of βLys87 to the Cα site, and the
concomitant buildup of positive charge at C4′ helps maintain
reaction specificity by disfavoring the competing transamination
pathway. These findings support the hypothesis that reaction
specificity in PLP-dependent enzymes is conferred in part by
the protonation states of ionizable groups on PLP and the
reacting substrates and that some PLP-dependent enzymes
eschew the stabilization of a canonical quinonoid form to
maintain this specificity. These results also underscore the
powerful role that NMR crystallography can play in character-
izing chemical structure within enzyme active sites, and its
ability, demonstrated here for the 2AP quinonoid intermediate,
to quantify fluctuations away from stable structures to transient
and more reactive species.
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